148 related articles for article (PubMed ID: 3379302)
1. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.
Schena PF; Pastore A; Sinico RA; Montinaro V; Fornasieri A
J Immunol; 1988 Jul; 141(1):125-30. PubMed ID: 3379302
[TBL] [Abstract][Full Text] [Related]
2. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
Chen A; Sheu LF; Ding SL; Lee WH
Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
[TBL] [Abstract][Full Text] [Related]
3. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
4. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
5. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
Sinico RA; Fornasieri A; Maldifassi P; Colasanti G; D'Amico G
Clin Nephrol; 1988 Oct; 30(4):182-6. PubMed ID: 3214964
[TBL] [Abstract][Full Text] [Related]
8. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
[No Abstract] [Full Text] [Related]
10. IgA related disorders in rheumatoid arthritis.
Pillemer SR; Reynolds WJ; Yoon SJ; Perera M; Newkirk M; Klein M
J Rheumatol; 1987 Oct; 14(5):880-6. PubMed ID: 2963127
[TBL] [Abstract][Full Text] [Related]
11. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
12. Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
Sinico RA; Fornasieri A; Oreni N; Benuzzi S; D'Amico G
J Immunol; 1986 Jul; 137(2):536-41. PubMed ID: 3722816
[TBL] [Abstract][Full Text] [Related]
13. IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome.
Atkinson JC; Fox PC; Travis WD; Popek E; Katz RW; Balow JE; Pillemer SR
J Rheumatol; 1989 Sep; 16(9):1205-10. PubMed ID: 2810277
[TBL] [Abstract][Full Text] [Related]
14. The role of IgA1 rheumatoid factor in the formation of IgA-containing immune complexes in Henoch-Schönlein purpura.
Saulsbury FT
J Clin Lab Immunol; 1987 Jul; 23(3):123-7. PubMed ID: 3669060
[TBL] [Abstract][Full Text] [Related]
15. Increased immunoglobulin-secreting cells in the blood of patients with active idiopathic IgA nephropathy.
Schena FP; Mastrolitti G; Fracasso AR; Pastore A; Ladisa N
Clin Nephrol; 1986 Oct; 26(4):163-8. PubMed ID: 3536230
[TBL] [Abstract][Full Text] [Related]
16. The role of polymeric IgA in complement-mediated solubilization of IgG and IgA immune complexes.
Schena FP; Pastore A; Montinaro V
Am J Kidney Dis; 1988 Nov; 12(5):433-6. PubMed ID: 3055971
[TBL] [Abstract][Full Text] [Related]
17. Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy.
González-Cabrero J; Egido J; Sancho J; Moldenhauer F
Clin Exp Immunol; 1987 Jun; 68(3):694-702. PubMed ID: 2443286
[TBL] [Abstract][Full Text] [Related]
18. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
Kerr MA; Wilton E; Naama JK; Whaley K
Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in patients with IgA glomerulonephritis.
Nagy J; Füst G; Ambrus M; Trinn C; Paál M; Burger T
Acta Med Acad Sci Hung; 1982; 39(3-4):211-8. PubMed ID: 6985242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
